Importantly, FGF2-induced phosphorylation of ERK1/2 within tumor organoids growing in a three-dimensional matrix that recapitulates the pulmonary microenvironment could be effectively blocked using two different pharmacological inhibitors of FGFR kinase activity (Figure 7A). Here, FGF2 is linked to neoplasm.